Combination of selected opioids with muscarine antagonists for treating urinary incontinence
申请人:Gruenenthal GmbH
公开号:US20040242617A1
公开(公告)日:2004-12-02
Active compound combinations of compounds of group A, particularly opioids, and compounds of group B, particularly anti-muscarine agents and other substances suitable for treatment of an increased urge to urinate or urinary incontinence. Related pharmaceutical formulations and methods of treatment of an increased urge to urinate or urinary incontinence are also provided.
The present invention directs to provide a novel compound for treating and/or preventing pain, having excellent skin permeation and reduced skin irritation. The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof (R
1
: a methyl group or other like group, R
2
: a fluorine atom or other like group, R
3
: a methyl group or other like group, R
4
: a methyl group or other like group, R
5
: a methyl group or other like group)
[EN] PROCESS FOR THE PREPARATION OF SUBSTITUTED 1-AMINOMETHYL-2-PHENYL-CYCLOHEXANE COMPOUNDS<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS DE 1-AMINOMÉTHYL-2-PHÉNYL-CYCLOHEXANE SUBSTITUÉS
申请人:GRUENENTHAL GMBH
公开号:WO2011147576A1
公开(公告)日:2011-12-01
The present invention relates to a process for the preparation of substituted 1-aminomethyl-2-phenyl-cyclohexane compounds.
本发明涉及一种制备取代的1-氨甲基-2-苯基环己烷化合物的方法。
PHARMACEUTICAL SALTS
申请人:GRÜNENTHAL GMBH
公开号:US20170137370A1
公开(公告)日:2017-05-18
The invention relates to pharmaceutical salts comprised of a pharmaceutical active substance and of at least one sugar substitute, to medicaments containing these salts, and to the use of these salts for producing medicaments.
1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
申请人:Friderichs Elmar
公开号:US20050182131A1
公开(公告)日:2005-08-18
The invention relates to metabolites of [2-(3-methoxyphenyl)-cyclohexylmethyl]-dimethylamine as free bases and/or in the form of physiologically acceptable salts, corresponding medicaments, the use of [2-(3-methoxyphenyl)-cyclohexylmethyl]-dimethylamine and the metabolites thereof for producing a medicament used for treating depression, and related methods of treating depression.